LENZ Therapeutics, Inc. (LENZ) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$69.17M | -16.5% |
| 2024 | -$59.39M | +1.6% |
| 2023 | -$60.38M | +31.4% |
| 2022 | -$87.98M | -66.5% |
| 2021 | -$52.85M | -506.0% |
| 2020 | -$8.72M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$69.17M | -16.5% |
| 2024 | -$59.39M | +1.6% |
| 2023 | -$60.38M | +31.4% |
| 2022 | -$87.98M | -66.5% |
| 2021 | -$52.85M | -506.0% |
| 2020 | -$8.72M | — |